To determine if deregulation of this silencing occurs in TAL1+ T-ALLs, ChIP-seq was also performed in the Jurkat (TAL1+) T-ALL cell-line and a control TAL1− sample (DA). Here, TAL1 is linked to acute lymphoblastic leukemia.